Overview

• Colgate-Palmolive posted Q4 adjusted earnings per share of $0.91, surpassing analyst estimates, but revenue of $4.94 billion fell short of the $4.97 billion forecast.
• Organic sales growth slowed to 4.3%, hindered by weak demand in North and Latin America and a decline in private label pet nutrition volumes.
• Foreign exchange rates negatively impacted revenue by 4.4%, with Latin America experiencing a 7.2% sales decline, while Europe, APAC, and Africa/Eurasia saw modest growth.
• The company’s FY25 guidance predicts flat revenue growth, factoring in a mid-single-digit negative impact from foreign exchange and a planned exit from private label pet nutrition.
• Despite challenges, analysts view Colgate-Palmolive as a high-quality company, benefiting from market share expansion and increased household penetration.